84TiPHER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib. (13th May 2019) - Tomasevic, Z; Smyth, L M; Saura, C; Boni, V; Garcia-Sáenz, J Á; Prat, A; Eli, L; Garza, S J; Lalani, A S; Crown, J P